In 1998 was created Catalyst Health Ventures, which is appeared as VC. The main office of represented VC is situated in the Braintree. The company was established in North America in United States.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Catalyst Health Ventures, startups are often financed by Versant Ventures, Tribeca Venture Partners, Rainfall Ventures. The meaningful sponsors for the fund in investment in the same round are Domain Associates, Tribeca Venture Partners, Rainfall Ventures. In the next rounds fund is usually obtained by Domain Associates, Upstart Capital, Tribeca Venture Partners.
The current fund was established by Kevin McCafferty. Besides them, we counted 7 critical employees of this fund in our database.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Maxwell Health, Sera Prognostics, Novazyme Pharmaceuticals. We can highlight the next thriving fund investment areas, such as Biotechnology, Education. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The increased amount of exits for fund were in 2018. Speaking about the real fund results, this VC is 23 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2011. Opposing the other organizations, this Catalyst Health Ventures works on 9 percentage points less the average amount of lead investments. The fund is constantly included in less than 2 deals per year.
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
PanTher Therapeutics | $5M | 19 May 2021 | Cambridge, Massachusetts, United States | ||
Instylla | $25M | 14 Oct 2020 | Massachusetts, United States | ||
AtaCor Medical | $25M | 28 Apr 2020 | San Clemente, California, United States | ||
Aria CV | $31M | 25 Feb 2020 | Saint Paul, Minnesota, United States | ||
Conformal Medical | $9M | 03 Dec 2018 | Nashua, New Hampshire, United States | ||
Saphena Medical | $1M | 01 Sep 2017 | Massachusetts, United States | ||
Cruzar Medsystems | $2M | 01 Jun 2017 | Massachusetts, United States | ||
nVision Medical | $12M | 21 Jul 2016 | California, United States | ||
Maxwell Health | $22M | 21 Mar 2016 | Boston, Massachusetts, United States |
– PanTher Therapeutics announced that it has closed an oversubscribed $5.4M Series A round led by Catalyst Health Ventures, with participation by Angel Physicians Fund and other notable investors.
– The Series A round brings the total amount raised by the company to $7.4M.
– Proceeds from the funding will go toward the company’s first-in-human clinical trial.
– The company also announced the additions of Darshana Zaveri, Managing Partner at CHV, Manish Bhandari, Managing Partner at APF, and Maria Palasis, President and CEO of Lyra Therapeutics, to its board of directors.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
PanTher Therapeutics | $5M | 19 May 2021 | Cambridge, Massachusetts, United States | ||
Instylla | $25M | 14 Oct 2020 | Massachusetts, United States | ||
AtaCor Medical | $25M | 28 Apr 2020 | San Clemente, California, United States | ||
Aria CV | $31M | 25 Feb 2020 | Saint Paul, Minnesota, United States | ||
Conformal Medical | $9M | 03 Dec 2018 | Nashua, New Hampshire, United States | ||
Saphena Medical | $1M | 01 Sep 2017 | Massachusetts, United States | ||
Cruzar Medsystems | $2M | 01 Jun 2017 | Massachusetts, United States | ||
nVision Medical | $12M | 21 Jul 2016 | California, United States | ||
Maxwell Health | $22M | 21 Mar 2016 | Boston, Massachusetts, United States |